Vanbinst R - Search Results

1

Computerized approach to monitoring aminoglycosides.

Leal T, Parez JJ, Vanbinst R, Wallemacq PE. Leal T, et al. Among authors: vanbinst r. Clin Chem. 1991 Aug;37(8):1415-9. Clin Chem. 1991. PMID: 1868604

2

Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.

Elens L, Veriter S, Di Fazio V, Vanbinst R, Boesmans D, Wallemacq P, Haufroid V. Elens L, et al. Among authors: vanbinst r. Clin Chem. 2009 Jan;55(1):170-4. doi: 10.1373/clinchem.2008.108647. Epub 2008 Nov 21. Clin Chem. 2009. PMID: 19028822

3

High-throughput liquid chromatography-tandem mass spectrometric analysis of sirolimus in whole blood.

Wallemacq PE, Vanbinst R, Asta S, Cooper DP. Wallemacq PE, et al. Among authors: vanbinst r. Clin Chem Lab Med. 2003 Jul;41(7):921-5. doi: 10.1515/CCLM.2003.140. Clin Chem Lab Med. 2003. PMID: 12940519

4

Plasma and tissue determination of 4-methylpyrazole for pharmacokinetic analysis in acute adult and pediatric methanol/ethylene glycol poisoning.

Wallemacq PE, Vanbinst R, Haufroid V, Di Fazio V, König J, Detaille T, Hantson P. Wallemacq PE, et al. Among authors: vanbinst r. Ther Drug Monit. 2004 Jun;26(3):258-62. doi: 10.1097/00007691-200406000-00006. Ther Drug Monit. 2004. PMID: 15167624 Clinical Trial.

5

Successful protocol of anaesthesia for measuring transepithelial nasal potential difference in spontaneously breathing mice.

Leal T, Lebacq J, Vanbinst R, Lederman Ch, De Kock M, Wallemacq P. Leal T, et al. Among authors: vanbinst r. Lab Anim. 2006 Jan;40(1):43-52. doi: 10.1258/002367706775404480. Lab Anim. 2006. PMID: 16460587

6

Evaluation of a new immunoassay to measure sirolimus blood concentrations compared to a tandem mass-spectrometric chromatographic analysis.

Fillée C, Mourad M, Squifflet JP, Malaise J, Lerut J, Reding R, Borghgraef P, Vanbinst R, Wallemacq PE. Fillée C, et al. Among authors: vanbinst r. Transplant Proc. 2005 Jul-Aug;37(6):2890-1. doi: 10.1016/j.transproceed.2005.05.034. Transplant Proc. 2005. PMID: 16182845

7

Alfentanil-induced miosis clearance as a liver CYP3A4 and 3A5 activity measure in healthy volunteers: improvement of experimental conditions.

Baririan N, Horsmans Y, Desager JP, Verbeeck R, Vanbinst R, Wallemacq P, Van Obbergh L. Baririan N, et al. Among authors: vanbinst r. J Clin Pharmacol. 2005 Dec;45(12):1434-41. doi: 10.1177/0091270005282629. J Clin Pharmacol. 2005. PMID: 16291719 Clinical Trial.

8

Permeability of 13 different gloves to 13 cytotoxic agents under controlled dynamic conditions.

Wallemacq PE, Capron A, Vanbinst R, Boeckmans E, Gillard J, Favier B. Wallemacq PE, et al. Among authors: vanbinst r. Am J Health Syst Pharm. 2006 Mar 15;63(6):547-56. doi: 10.2146/ajhp050197. Am J Health Syst Pharm. 2006. PMID: 16522891

9

Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection.

Capron A, Lerut J, Verbaandert C, Mathys J, Ciccarelli O, Vanbinst R, Roggen F, De Reyck C, Lemaire J, Wallemacq PE. Capron A, et al. Among authors: vanbinst r. Ther Drug Monit. 2007 Jun;29(3):340-8. doi: 10.1097/FTD.0b013e31805c73f1. Ther Drug Monit. 2007. PMID: 17529892

10

A fast ultra-performance liquid chromatography method for simultaneous quantification of mycophenolic acid and its phenol- and acyl-glucuronides in human plasma.

Musuamba FT, Di Fazio V, Vanbinst R, Wallemacq P. Musuamba FT, et al. Among authors: vanbinst r. Ther Drug Monit. 2009 Feb;31(1):110-5. doi: 10.1097/FTD.0b013e318191897d. Ther Drug Monit. 2009. PMID: 19057465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters